The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127744021 12774402 1 I 20160909 20160923 20160923 PER US-JNJFOC-20160910588 JOHNSON AND JOHNSON 9.00 DEC E F Y 56.25000 KG 20160923 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127744021 12774402 1 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 0 10 MG TABLET QD
127744021 12774402 2 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 0 10 MG TABLET QD
127744021 12774402 3 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral 1/2 TABLET N 471351;467858 0 5 MG TABLET QD
127744021 12774402 4 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral 1/2 TABLET N 471351;467858 0 5 MG TABLET QD
127744021 12774402 5 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 0 10 MG TABLET QD
127744021 12774402 6 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 0 10 MG TABLET QD
127744021 12774402 7 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral 1/2 TABLET N 471351;467858 0 5 MG TABLET QD
127744021 12774402 8 PS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 19835 10 MG TABLET QD
127744021 12774402 9 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral N 471351;467858 19835 10 MG TABLET QD
127744021 12774402 10 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown YEARS D 0 88 MG UNSPECIFIED
127744021 12774402 11 C VERAPAMIL VERAPAMIL HYDROCHLORIDE 1 Unknown 3-4 YEARS D 0 120 MG UNSPECIFIED
127744021 12774402 12 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Unknown D 0 1 DF UNSPECIFIED
127744021 12774402 13 C ALL OTHER THERAPEUTIC PRODUCTS UNSPECIFIED INGREDIENT 1 Unknown EVERY OTHER DAY FOR 6 MONTHS D 0 1 DF

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127744021 12774402 1 Lacrimation increased
127744021 12774402 2 Lacrimation increased
127744021 12774402 3 Lacrimation increased
127744021 12774402 4 Rhinorrhoea
127744021 12774402 5 Rhinorrhoea
127744021 12774402 6 Rhinorrhoea
127744021 12774402 7 Cough
127744021 12774402 8 Cough
127744021 12774402 9 Cough
127744021 12774402 10 Thyroid disorder
127744021 12774402 11 Atrial fibrillation
127744021 12774402 12 Nutritional supplementation
127744021 12774402 13 Cataract

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127744021 12774402 Lethargy
127744021 12774402 Off label use
127744021 12774402 Product packaging issue
127744021 12774402 Product use issue
127744021 12774402 Somnolence
127744021 12774402 Therapeutic response unexpected

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127744021 12774402 1 2016 2016 0
127744021 12774402 2 2016 0
127744021 12774402 3 2016 0
127744021 12774402 4 2016 0
127744021 12774402 5 2016 0
127744021 12774402 6 2016 2016 0
127744021 12774402 7 2016 0
127744021 12774402 8 2016 0
127744021 12774402 9 2016 2016 0